To The Moon

$Gilead Sciences(GILD)$

$Gilead Sciences(GILD) Holds +0.94% at $147.68: Defensive Biotech Regains Momentum, $149 Resistance Eyed 🔬

Latest Close: GILD settled at $147.68 (+0.94%), just 6.1% below its 52-week high of $157.29. Intraday range held tight at $146.12–$149.30.

Core Market Drivers: Biotech sentiment stabilized after recent sector-wide pressure. GILD's HIV franchise remains a defensive anchor, with Trodelvy's EU/US approvals in triple-negative breast cancer providing a steady catalyst pipeline. Broader healthcare rotation supported large-cap pharma.

Technical Analysis: Volume was moderate at 5.19M shares (VR 1.07), showing no distribution panic. MACD remains negative at -1.45 (DIF 2.18 vs DEA 2.90), but the histogram is narrowing, signaling downside momentum fading. RSI(6) rebounded to 57.5 from oversold 32.9, confirming a bullish reversal attempt. KDJ shows a fresh bullish cross with J-value spiking to 40.5.

Key Price Levels:

• 🟢 Primary Support: $132.03

• 🔴 Strong Resistance: $149.46

• ⚡ Immediate Pivot: $146.30 (yesterday's close)

Valuation Perspective: P/E TTM is negative at -56.5 due to recent impairment charges, while P/S stands at 6.02 — elevated versus historical pharma norms, reflecting pipeline optimism rather than current earnings power. Forward P/E has collapsed to -330, indicating expected near-term losses.

Analyst Targets: 27 institutions cover GILD with a mean target of $158.53 (range $123–$180). Breakdown: 7 Strong Buy, 18 Buy, 6 Hold — overwhelmingly constructive long-term positioning.

Weekly Outlook: Expect oscillation between $144–$152. A decisive break above $149.46 activates a measured move toward $157.29; failure at $146 opens a retest of $132. A bullish MACD crossover next week would confirm the reversal.

⚠️ Not financial advice. Technical indicators reflect historical patterns and may fail under changing market conditions.

🎯$Gilead Sciences(GILD) Options Strategy: Bull Call Spread (Debit Spread)

• Underlying: GILD

• View: Cautiously bullish; short-term oversold bounce toward resistance

• Strategy Type: Debit spread / directional long with defined risk

• Option Contract Portfolio (simulated):

  • Buy to Open: GILD 2026-09-25 145 Call @ $3.00 (mid ~$3.35–$3.725; use conservative $3.00 executable)

  • Sell to Open: GILD 2026-09-25 150 Call @ $1.44 (mid ~$1.61–$1.64; use conservative $1.44 credit)

• Max Gain & Loss:

  • Maximum Gain: $3.56 per share ($356 per contract) = (150 − 145) − ($3.00 − $1.44) = $5.00 − $1.56

  • Maximum Loss: $1.56 per share ($156 per contract) = net debit paid

• Initial Cost/Credit: $1.56 net debit per share ($156 per contract)

Markets are always moving - and sometimes, the best move is knowing what works for you.

With Treasury yields, oil prices and rate expectations keeping markets on edge this week, investors are once again thinking carefully about where to position next. There’s no one-size-fits-all choice in investing — and the same goes for Tiger Merch. This month’s hot picks are in, featuring the Tiger Toiletry Bag, Universal Travel Adapter, Tiger Umbrella and more favourites chosen by fellow Tigers.

Explore the Monthly Hot Picks in Tiger Coin Mall, now 12% OFF for a limited time.

https://laohu8.com/J/redeemGift?goodID=100561&type=delivery